If you are going to publish in Nature next week, or believe your results could be patented,
take a look at Hivebench's signatures and audit trails.
Stop thinking security and usability cannot work together...
Just enjoy to use Hivebench on a day-to-day basis!
Research is a collaborative process, and sharing knowledge allows you to save time and value your results.
Learn how to manage reagents and protocols with teammates and create notebooks to work together.
With Hivebench, you will easily create a knowledge database and maintain your Lab memory.
You create your account online.
Then you will create your notebook and invite teammates to collaborate.
Hivebench is an online service.
We make it simple to delete your account at any time.
At this time, Hivebench is Free for online accounts. You can also install Hivebench on your own servers at a cost.
Hivebench will help you to manage your protocols, experiments, results... at desk or at bench using the iPad/iPhone app.
Yes, you can invite unlimited number of colleagues to work with you on your notebooks. It will be Free for them too.
How can we help you?
You don't see your questions?
Please, contact us.
Apple, the Apple logo, iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.
Access to your data is controlled and restricted using authentication protocol (username and password).
We contractually protect your data (private and research) and store in a secure data center.
If you have any question or need technical assistance, please contact us at email@example.com
Hivebench uses cloud computing technologies to secure your data while allowing you to access it from anywhere.
HTTP and SSL connections protect sensitive data transmitted to and from Hivebench.
We use the secure Amazon Web Service (AWS) technology to store your data.
Your data is backed up regularly to ensure recovery from our postgres database.
We use electronic signature to warranty the property of your data. It's the first step towards FDA 21 CFR Part 11.